NYSE$XRN

Global Medical REIT Inc · Q1 2024 earnings

Q1 2024 earnings · · Investor relations

Briefing

Delivered steady results due to portfolio quality and tenant base resilience.

Global Medical REIT reported a decrease in rental revenue by 3.0% year-over-year to $35.1 million for Q1 2024, primarily due to property dispositions in 2023. Net income attributable to common stockholders totaled $0.8 million, or $0.01 per diluted share. The company reported FFO of $14.9 million, or $0.21 per share and unit, and AFFO of $16.5 million, or $0.23 per share and unit.

  • Rental revenue decreased 3.0% year-over-year to $35.1 million.
  • Net income attributable to common stockholders totaled $0.8 million, or $0.01 per diluted share.
  • FFO was $14.9 million, or $0.21 per share and unit.
  • AFFO was $16.5 million, or $0.23 per share and unit.

Headline financials

Total Revenue

$35.1M

Previous: $36.2M-3.1%
EPS

$0.01

Previous: $0.23-95.7%
WALT

5.8

Previous: 6-3.3%
Leverage

44.0%

No prior period
Net Income

$2.31M

Previous: $2.17M+6.5%
Operating Income

$2.31M

Previous: $1.69M+37.1%
Gross Profit

$35.1M

Previous: $36.2M-3.1%
Cash & Equivalents

$1.33M

Previous: $4.6M-71.0%
Total Assets

$1.26B

Previous: $1.37B-7.7%
Stock-Based Comp

$1.23M

Previous: $688K+79.2%

Revenue & EPS history

Global Medical REIT · Revenue · Quarterly

$35.1M

Q1 2024-3.1%vs Q1 2023
Beat estimate in 5 of 13 quarters(38%)
ActualEstimate

Forward guidance

The Company expects to complete the acquisition of a 15-property portfolio of outpatient medical real estate for an aggregate purchase price of $81.3 million in two tranches, with the first tranche closing in the third quarter of 2024 and the remainder closing in the fourth quarter of 2024.

Tailwinds

  • Acquisition of a 15-property portfolio of outpatient medical real estate expected to close in two tranches.
  • First tranche of the acquisition, approximately $30 million - $35 million, expected to close in the third quarter of 2024.
  • Remaining portion of the acquisition expected to close in the fourth quarter of 2024.
  • The properties are fully occupied.
  • The properties are leased under triple-net or absolute triple-net leases.

Headwinds

  • The Company’s obligation to close the acquisition is subject to certain customary terms and conditions, including due diligence reviews.
  • There is no assurance that the Company will close this acquisition on a timely basis.
  • There is no assurance that the Company will close this acquisition at all.
  • Steward Health Care, representing 2.8% of the Company’s annualized base rent, filed for Chapter 11 bankruptcy reorganization.
  • There can be no assurances that the Company will receive any amounts owed to it by Steward.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q1 2024

Historical avgQ1 2024

+0.2%

Avg return

Earnings day

+0.9%

Avg return

5 days after

+1.1%

Avg return

30 days after

56%

22 / 39 earnings

Positive

+7.3%

Q4 2016

Best reaction

-9.8%

Q1 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-9.2%-4.2%
Q4 2025-1.6%-2.6%-13.2%
Q3 2025+1.8%+3.2%+1.7%
Q1 2025-9.8%-11.7%-17.0%
Q4 2024+3.8%+4.4%+3.1%
Q3 2024-2.6%-3.6%-7.4%
Q2 2024-1.8%-0.3%+1.0%
Q1 2024+3.4%+4.8%+8.4%
Q4 2023-5.6%-2.7%-5.7%
Q3 2023-1.8%-0.8%+11.7%
Q2 2023+3.5%+4.8%-1.5%
Q1 2023+0.8%+1.8%+1.9%
Q4 2022-4.0%-1.2%-13.0%
Q3 2022-0.9%+0.2%+12.3%
Q2 2022-0.5%-1.3%-11.0%
Q1 2022-5.3%-11.9%-12.5%
Q4 2021-3.2%-2.2%+1.9%
Q3 2021+1.6%+1.0%-2.5%
Q2 2021-0.7%-0.2%+3.7%
Q1 2021-1.2%+1.0%+5.2%
Q4 2020+1.6%+3.9%+0.2%
Q3 2020+2.0%+1.4%+7.2%
Q2 2020+4.8%+11.4%+11.6%
Q1 2020+7.0%+9.3%+26.0%
Q4 2019+4.7%-7.2%-41.1%
Q3 2019+2.3%+9.5%+22.4%
Q2 2019-0.7%+1.8%+5.0%
Q1 2019+1.4%+4.5%+7.1%
Q4 2018+0.8%+2.6%-2.0%
Q3 2018+2.2%+2.0%+6.4%
Q2 2018+4.3%+6.7%+12.2%
Q1 2018+2.6%-0.1%+4.6%
Q4 2017+5.8%+6.3%+3.9%
Q3 2017+3.1%+3.7%-2.8%
Q2 2017+0.7%+2.8%+2.8%
Q1 2017-1.2%+0.0%+0.3%
Q4 2016+7.3%+9.3%+17.1%
Q3 2016-8.5%-14.9%-0.2%
Q2 2016+1.1%+2.3%-5.0%
Q1 2016
Q4 2015
Q3 2015
Q2 2015
Q1 2015
Q4 2014
Q3 2014
Q2 2014
Q1 2014
Q4 2013
Q3 2013
Q2 2013
Q1 2013
Q4 2012
Q3 2012
Q2 2012
Q1 2011
Q4 2011

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro